Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Non-Current Deffered Revenue (2012 - 2014)

Insmed (INSM) posted Non-Current Deffered Revenue of $118000.0 for Q4 2014, down 36.22% on a QoQ basis from $185000.0 in Q3 2014, and down 68.95% year-over-year from $380000.0 in Q4 2013.

Analysis

Insmed (INSM) Non-Current Deffered Revenue (2012 - 2014) Analysis & Trends

Insmed has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $118000.0 in Q4 2014.

  • On a quarterly basis, Non-Current Deffered Revenue fell 68.95% year-over-year to $118000.0 in Q4 2014; TTM through Dec 2014 was $118000.0, a 68.95% decrease from a year earlier, with the FY2014 full-year figure at $118000.0, down 68.95% from the prior year.
  • Non-Current Deffered Revenue was $118000.0 for Q4 2014 at Insmed, down from $185000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $647000.0 in Q4 2012, with the low at $118000.0 in Q4 2014.
  • Average Non-Current Deffered Revenue over 3 years is $382000.0, with a median of $380000.0 recorded in 2013.
  • The sharpest annual moves came in 2013 and 2014: Non-Current Deffered Revenue sank 41.27% in 2013, then slumped 68.95% in 2014.
  • Over 3 years, Non-Current Deffered Revenue stood at $647000.0 in 2012, then tumbled by 41.27% to $380000.0 in 2013, then plunged by 68.95% to $118000.0 in 2014.
  • The last three Non-Current Deffered Revenue figures came in at $118000.0 (Q4 2014), $185000.0 (Q3 2014), and $250000.0 (Q2 2014), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 220.40 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 147.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 118,000.00
Sep 30, 2014 185,000.00
Jun 30, 2014 250,000.00
Mar 31, 2014 315,000.00
Dec 31, 2013 380,000.00
Sep 30, 2013 449,000.00
Jun 30, 2013 514,000.00
Mar 31, 2013 580,000.00
Dec 31, 2012 647,000.00